Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...

PET scans can detect amyloid plaques and tau tangles in the brain, which are often early signs of Alzheimer’s disease. But they’re not enough on their own to make a diagnosis. Alzheimer’s disease is ...

A new brain imaging study provides evidence that high levels of iron in certain parts of the brain may signal an increased risk of developing cognitive problems years before symptoms appear. The study ...

Elevated brain iron, measured using quantitative susceptibility mapping MRI, may help predict the onset of mild cognitive ...

Scientists developed a non-invasive MRI technique to measure brain iron levels, which may help identify patients at higher ...

Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...

An advanced AI tool can detect tiny brain lesions that cause severe epilepsy in children, allowing faster diagnosis, more ...

Aug. 13 -- TUESDAY, Aug. 12 (HealthDay News) -- PET scans may provide doctors with a non-invasive method of detecting Alzheimer's disease-related brain plaques, Finnish researchers say. Currently, the ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

PET scans showing brain estrogen receptor (ER) density in a premenopausal (left) and a postmenopausal (right) woman. The color scale reflects brain ER density, with brighter colors indicating more ...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company ...